Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma
- 31 October 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (9) , 565-569
- https://doi.org/10.1038/sj.bmt.1703725
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two casesBone Marrow Transplantation, 1999
- Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approachesJournal of Inorganic Biochemistry, 1999
- Medulloblastoma in adults: clinical characteristics and treatmentCancer Treatment Reviews, 1999
- High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.Journal of Clinical Oncology, 1997
- Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.Journal of Clinical Oncology, 1996
- Surveillance Scanning of Children with MedulloblastomaNew England Journal of Medicine, 1994
- High Dose Chemotherapy with Autologous Bone Marrow Rescue for High Grade Gliomas of the Brain: A Potential for Improvement in Therapeutic ResultsNeurosurgery, 1984
- Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762) (MOPP vs OPP) in children with recurrent brain tumorsMedical and Pediatric Oncology, 1984
- Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastomaCancer, 1983
- Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristineJournal of Neurosurgery, 1978